Aurobindo Pharma Ltd.
BSE: 524804 | Sector: Health care |
NSE: AUROPHARMA | ISIN Code: INE406A01037 |
BSE 00:00 | 13 Apr | 909.75 |
-6.40 (-0.70%) |
OPEN
919.00 |
HIGH
924.95 |
LOW
887.10 |
NSE 00:00 | 13 Apr | 909.25 |
-5.95 (-0.65%) |
OPEN
917.10 |
HIGH
925.00 |
LOW
889.50 |
OPEN | 919.00 |
PREVIOUS CLOSE | 916.15 |
VOLUME | 113065 |
52-Week high | 1023.10 |
52-Week low | 464.35 |
P/E | 17.88 |
Mkt Cap.(Rs cr) | 53,302 |
Buy Price | 0.00 |
Buy Qty | 0.00 |
Sell Price | 0.00 |
Sell Qty | 0.00 |
- Financial Overview
- Balance Sheet
- Profit & Loss
- Cash Flow
- Ratios
- Quarterly
- Half Yearly
- Nine Monthly
- Yearly
Filter:
Aurobindo Pharma Ltd. (AUROPHARMA) - Cash Flow
Figures in Rs crore | 2020 | 2019 | 2018 |
Opening Cash & Cash Equivalents | 68.70 | 239.95 | -131.54 |
Net Cash From Operating Activities | 2161.73 | 529.89 | 922.40 |
Net Cash Used In/from Investing Activities | -918.60 | -1300.54 | -990.60 |
Net Cash Used In/from Financing Activities | -1252.39 | 599.40 | 439.69 |
Net (decrease)/increase In Cash and Cash Equivalents |
-9.26 | -171.25 | 371.49 |
Closing Cash & Cash Equivalents | 59.44 | 68.70 | 239.95 |
Quick Links for Aurobindo Pharma:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices